Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

Umaña, Pablo, Jean–Mairet, Joël, Moudry, Radmila, Amstutz, Hanspeter, Bailey, James E.·1999·Nature Biotechnology

Cited by (764)

Items 201–300 of 764

  1. Post-translational modification of plant-made foreign proteins; glycosylation and beyond.
    D. Webster, M. Thomas · 2012 · Biotechnology Advances
  2. Moss bioreactors producing improved biopharmaceuticals
    Eva L. Decker, Ralf Reski A · 2007 · Current Opinion in Biotechnology
  3. Structural analysis of Fc/FcγR complexes: a blueprint for antibody design
    José M. M. Caaveiro, Masato Kiyoshi, Kouhei Tsumoto · 2015 · Immunological Reviews
  4. Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy
    Rose Ghemrawi, Lama Abuamer, Sedra Kremesh, Ghadeer Hussien, Rahaf Ahmed, Walaa Kamel Mousa, Ghalia Khoder, Mostafa Khair · 2024 · Biomedicines
  5. Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity
    Whitney Shatz-Binder, Shan Chung, Bing Li, Brett Marshall, Max L. Tejada, Wilson Phung, Wendy N. Sandoval, Robert F. Kelley, Justin M. Scheer · 2013 · mAbs
  6. Design of humanized antibodies: From anti-Tac to Zenapax
    Naoya Tsurushita, Paul R. Hinton, Shankar Kumar · 2005 · Methods
  7. Profiling analysis of oligosaccharides in antibody pharmaceuticals by capillary electrophoresis
    Satoru Kamoda, Chie Nomura, Mitsuhiro Kinoshita, Saori Nishiura, Rika Ishikawa, Kazuaki Kakehi, Nana Kawasaki, Takao Hayakawa · 2004 · Journal of Chromatography A
  8. Streptomyces-derived quorum-sensing systems engineered for adjustable transgene expression in mammalian cells and mice
    Wilfried Weber · 2003 · Nucleic Acids Research
  9. Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies
    Thomas R. W. Tipton, Ali Roghanian, Robert J. Oldham, Matthew J. Carter, Kerry L. Cox, Christopher Ian Mockridge, Ruth R. French, Lekh N. Dahal, Patrick J. Duriez, Philip G. Hargreaves et al. · 2015 · Blood
  10. A Single Excitation‐Duplexed Imaging Strategy for Profiling Cell Surface Protein‐Specific Glycoforms
    Na Wu, Lei Bao, Lin Ding, Huangxian Ju · 2016 · Angewandte Chemie International Edition
  11. A temperature-regulated replicon-based DNA expression system
    Marco Boorsma, Lars Nieba, Daniel Koller, Martin F. Bachmann, James E. Bailey, Wolfgang A. Renner · 2000 · Nature Biotechnology
  12. Using glyco-engineering to produce therapeutic proteins
    Martina Dicker, R. Strasser · 2015 · Expert Opinion on Biological Therapy
  13. Systems biotechnology of mammalian cell factories
    Peter M. O’Callaghan, David C. James · 2008 · Briefings in Functional Genomics and Proteomics
  14. Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized Therapies
    Guillaume Cartron, Ralf Ulrich Trappe, Philippe Solal‐Céligny, Michael J. Hallek · 2011 · Clinical Cancer Research
  15. Antibody manufacture in transgenic animals and comparisons with other systems
    Louis‐Marie Houdebine · 2002 · Current Opinion in Biotechnology
  16. Impact of Differential Glycosylation on IgG Activity
    Anja Lux, Falk Nimmerjahn · 2011 · Advances in experimental medicine and biology
  17. Protein Glycoengineering: An Approach for Improving Protein Properties
    Bo Ma, Xiaoyang Guan, Yaohao Li, Shiying Shang, Jing Li, Zhongping Tan · 2020 · Frontiers in Chemistry
  18. Analysis of Nonhuman N-Glycans as the Minor Constituents in Recombinant Monoclonal Antibody Pharmaceuticals
    Eiki Maeda, Soichiro Kita, Mitsuhiro Kinoshita, Koji Urakami, Takao Hayakawa, Kazuaki Kakehi · 2012 · Analytical Chemistry
  19. Modulating Antibody Functionality in Infectious Disease and Vaccination
    Bronwyn M. Gunn, Galit Alter · 2016 · Trends in Molecular Medicine
  20. Post-translational structural modifications of immunoglobulin G and their effect on biological activity
    Laura K. Hmiel, Kurt Brorson, Michael T. Boyne · 2014 · Analytical and Bioanalytical Chemistry
  21. Cell Type-Specific and Site Directed N-Glycosylation Pattern of FcγRIIIa
    Anne Zeck, Gottfried Pohlentz, Tilman Schlothauer, Jasna Peter‐Katalinić, Jörg T. Regula · 2011 · Journal of Proteome Research
  22. GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins
    Alain Beck, Olivier Cochet, Thierry Wurch · 2009 · Expert Opinion on Drug Discovery
  23. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus
    Christopher Sjöwall, J Zapf, Sarah von Löhneysen, I Magorivska, Mona H. C. Biermann, Christina Janko, Silke Winkler, Rostyslav O. Bilyy, Georg Andreas Schett, Martin Herrmann i et al. · 2014 · Lupus
  24. Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
    Hilma J. van der Horst, Inger S. Nijhof, Tuna Mutis, Martine E.D. Chamuleau · 2020 · Cancers
  25. Building better magic bullets — improving unconjugated monoclonal antibody therapy for cancer
    Louis M. Weiner · 2007 · Nature reviews. Cancer
  26. Human Immunoglobulin G2 (IgG2) and IgG4, but Not IgG1 or IgG3, Protect Mice against Cryptococcus neoformans Infection
    David O. Beenhouwer, Esther M. Yoo, Chunwei Walter Lai, Miguel A. Rocha, Sherie Leaver Morrison · 2007 · Infection and Immunity
  27. The importance of IgG glycosylation—What did we learn after analyzing over 100,000 individuals
    Jasminka Krištić, Gordan Lauc · 2024 · Immunological Reviews
  28. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding
    M. Jack Borrok, Nadia Luheshi, Nurten Beyaz, Gareth C. Davies, James William Legg, Herren Wu, William F. Dall’Acqua, Ping Tsui · 2015 · mAbs
  29. Small-molecule control of antibody N-glycosylation in engineered mammalian cells
    Michelle M. Chang, Leonid Gaidukov, Giyoung Jung, Wen Allen Tseng, John J. Scarcelli, Richard J. Cornell, Jeffrey K. Marshall, Jonathan L. Lyles, Paul Sakorafas, An‐Hsiang Adam Chu et al. · 2019 · Nature Chemical Biology
  30. A Mutual Regulation between Cell−Cell Adhesion and N-Glycosylation: Implication of the Bisecting GlcNAc for Biological Functions
    Jianguo Gu, Yuya Sato, Yoshinobu Kariya, Tomoya Isaji, Naoyuki Taniguchi, Tomohiko Fukuda · 2008 · Journal of Proteome Research
  31. Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody
    Alexandra Castilho, Natasha Bohorova, Josephine Grass, Ognian Bohorov, Larry Zeitlin, Kevin J. Whaley, Friedrich Altmann, Herta Steinkellner · 2011 · PLoS ONE
  32. Establishment of a Human Somatic Hybrid Cell Line for Recombinant Protein Production
    M. S. Cho, Helena Yee, S. Chan · 2002 · Journal of Biomedical Science
  33. Effective Phagocytosis of Low Her2 Tumor Cell Lines with Engineered, Aglycosylated IgG Displaying High FcγRIIa Affinity and Selectivity
    Sang Taek Jung, William Kelton, Tae Hyun Kang, Daphne T. W. Ng, Jan Terje Andersen, Inger Sandlie, Casim A. Sarkar, George Georgiou · 2012 · ACS Chemical Biology
  34. Antibody cocktails: next-generation biopharmaceuticals with improved potency
    Ton Logtenberg · 2007 · Trends in biotechnology
  35. Single-Domain Antibody–Based and Linker-Free Bispecific Antibodies Targeting FcγRIII Induce Potent Antitumor Activity without Recruiting Regulatory T Cells
    Caroline Rozan, Amélie Cornillon, Corinne Pétiard, Martine Chartier, Ghislaine Béhar, Charlotte Boix, Brigitte Kerfélec, Bruno Robert, André Pèlegrin, Patrick Chames et al. · 2013 · Molecular Cancer Therapeutics
  36. Glycoengineering in CHO cells: advances in systems biology
    Tejwani, Vijay, Andersen, Mikael R., Nam, Jong Hyun, Sharfstein, Susan T. · 2018 · Biotechnology Journal
  37. Chemoenzymatic Fc Glycosylation via Engineered Aldehyde Tags
    Elizabeth L. Smith, John P. Giddens, Anthony T. Iavarone, Kamil Godula, Lai‐Xi Wang, Carolyn Ruth Bertozzi · 2014 · Bioconjugate Chemistry
  38. A chemically modified antibody mediates complete eradication of tumours by selective disruption of tumour blood vessels
    A Palumbo, F Hauler, Piotr Dziunycz, Kathrin Schwager, Alex Soltermann, Francesca Pretto, C Alonso, Günther F.L. Hofbauer, Ross W. Boyle, Dario Neri · 2011 · British Journal of Cancer
  39. Molecular engineering of exocytic vesicle traffic enhances the productivity of Chinese hamster ovary cells
    Ren‐Wang Peng, Martin Fussenegger · 2008 · Biotechnology and Bioengineering
  40. Transient Glyco-Engineering to Produce Recombinant IgA1 with Defined N- and O-Glycans in Plants
    Martina Dicker, Marc Tschofen, Daniel Maresch, Julia König-Beihammer, Paloma Juárez, Diego Orzáez, Friedrich Altmann, Herta Steinkellner, Richard Strasser · 2016 · Frontiers in Plant Science
  41. Molecular targeting of angiogenesis
    Patrizia Alessi, Christina Ebbinghaus, Dario Neri · 2003 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  42. Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation
    Josée Golay, Rut Valgardsdottir, Gerta Musaraj, Damiano Giupponi, Orietta Spinelli, Martino Introna · 2019 · Blood
  43. Boosting ADCC and CDC activity by Fc engineering and evaluation of antibody effector functions
    Christian Kellner, Stefanie Derer, Thomas Valerius, Matthias Peipp · 2013 · Methods
  44. Targeting the Fc receptor in autoimmune disease
    Xinrui Li, Robert P. Kimberly · 2014 · Expert Opinion on Therapeutic Targets
  45. N-Glycosylation of IgG and IgG-Like Recombinant Therapeutic Proteins: Why Is It Important and How Can We Control It?
    Natalia I. Majewska, Max L. Tejada, Michael J. Betenbaugh, Nitin Agarwal · 2020 · Annual Review of Chemical and Biomolecular Engineering
  46. Tailor-made antibody therapeutics
    Partha Sarathi Chowdhury, Herren Wu · 2005 · Methods
  47. 1.3 General formulas for two-particle reactions
    H. Pilkuhn · 2005 · Springer eBooks
  48. High-throughput immunoglobulin G N-glycan characterization using rapid resolution reverse-phase chromatography tandem mass spectrometry
    Bradley D. Prater, Heather M. Connelly, Qiang Qin, Steven L. Cockrill · 2008 · Analytical Biochemistry
  49. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III
    Gerard Rouwendal, Manfred Wuhrer, Dion E. A. Florack, Carolien A. M. Koeleman, André M. Deelder, Hans Bakker, Geert M. Stoopen, Irma van Die, Johannes P. F. G. Helsper, Cornelis Hendrik Hokke et al. · 2006 · Glycobiology
  50. Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity
    Kristina Ellwanger, Uwe Reusch, Ivica Fucek, Susanne Wingert, Thorsten Ross, Thomas R Müller, Ute Schniegler‐Mattox, Torsten Haneke, Erich Rajkovic, Joachim Koch et al. · 2019 · mAbs
  51. The advent of plant cells in bioreactors
    Fuensanta Verdú Navarro, Juan A. Moreno-Cid, Julia Weiß, Marcos Egea‐Cortines · 2023 · Frontiers in Plant Science
  52. Crystal structure of Streptococcus pyogenes EndoS, an immunomodulatory endoglycosidase specific for human IgG antibodies
    Beatriz Trastoy, Joseph V. Lomino, Brian G. Pierce, Lester G. Carter, Sebastian Günther, John P. Giddens, Greg A. Snyder, Thomas M Weiss, Zhiping Weng, Lai‐Xi Wang et al. · 2014 · Proceedings of the National Academy of Sciences
  53. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region
    Akito Natsume, Masako Wakitani, Naoko Yamane‐Ohnuki, Emi Shoji-Hosaka, Rinpei Niwa, Kazuhisa Uchida, Mitsuo Satoh, Kenya Shitara · 2005 · Journal of Immunological Methods
  54. Glycosylation profiles of therapeutic antibody pharmaceuticals
    Christoph Wacker, Christoph N. Berger, Philippe Girard, Roger Meier · 2011 · European Journal of Pharmaceutics and Biopharmaceutics
  55. Glycosylation Shapes the Efficacy and Safety of Diverse Protein, Gene and Cell Therapies
    Frances Rocamora, Angelo Gabriel Peralta, Seunghyeon Shin, James Sorrentino, Mina Ying Min Wu, Eric A. Toth, Thomas R. Fuerst, Nathan E. Lewis · 2023 · Biotechnology Advances
  56. Antibody engineering: facing new challenges in cancer therapy
    Laura Sanz, Ángel M. Cuesta, Marta Compte, Luis Álvarez‐Vallina · 2005 · Acta Pharmacologica Sinica
  57. Fibroblast growth factors in cancer: therapeutic possibilities
    Michael Jeffers, William J. LaRochelle, Henri S. Lichenstein · 2002 · Expert Opinion on Therapeutic Targets
  58. Glycosylation of monoclonal antibody products: Current status and future prospects
    Jyoti Batra, Anurag Singh Rathore · 2016 · Biotechnology Progress
  59. Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering
    Xiaojie Yu, Michael J. E. Marshall, Mark Steven Cragg, Max Crispin · 2017 · BioDrugs
  60. N-glycans as functional effectors of genetic and epigenetic disease risk
    Tamara Štambuk, Marija Klasić, Vlatka Zoldoš, Gordan Lauc · 2020 · Molecular Aspects of Medicine
  61. Glycosylation Biomarkers Associated with Age-Related Diseases and Current Methods for Glycan Analysis
    Beatrix Paton, Manuel Suárez, Pol Herrero, Núria Canela-Canela · 2021 · International Journal of Molecular Sciences
  62. Capillary electrophoresis-electrospray ionization mass spectrometry for rapid and sensitive N-glycan analysis of glycoproteins as 9-fluorenylmethyl derivatives
    M. Nakano, Daisuke Higo, E. Arai, T. Nakagawa, Kazuaki Kakehi, Naoyuki Taniguchi, Akihiro Kondo · 2008 · Glycobiology
  63. New Directions in Glycoprotein Engineering
    Derek Macmillan, Carolyn Ruth Bertozzi · 2000 · Tetrahedron
  64. High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples
    Dietmar Reusch, Markus Haberger, Maurice H. J. Selman, Patrick Bulau, André M. Deelder, Manfred Wuhrer, Niklas Engler · 2012 · Analytical Biochemistry
  65. Processing of complex N-glycans in IgG Fc-region is affected by core fucosylation
    Alexandra Castilho, Clemens Grünwald‐Gruber, A. Thader, Chris Oostenbrink, Maria Pechlaner, Herta Steinkellner, Friedrich Altmann · 2015 · mAbs
  66. High-throughput glycosylation analysis of therapeutic immunoglobulin G by capillary gel electrophoresis using a DNA analyzer
    Dietmar Reusch, Markus Haberger, Tobias Kailich, Anna-Katharina Heidenreich, Michael Kampe, Patrick Bulau, Manfred Wuhrer · 2013 · mAbs
  67. Intravital imaging reveals improved Kupffer cell-mediated phagocytosis as a mode of action of glycoengineered anti-CD20 antibodies
    Capucine L. Grandjean, Fabrício Montalvão, Susanna Celli, David Michonneau, Béatrice Bréart, Zacarias Garcia, Mario Perro, Olivier Freytag, Christian A. Gerdes, Philippe Bousso · 2016 · Scientific Reports
  68. Mechanisms of Resistance to NK Cell Immunotherapy
    Christian Sordo‐Bahamonde, Massimo Vitale, Seila Lorenzo‐Herrero, Alejandro López‐Soto, Segundo R. Gonzalez · 2020 · Cancers
  69. Myeloma expression systems
    Esther M. Yoo, Koteswara R. Chintalacharuvu, Manuel L. Penichet, Sherie Leaver Morrison · 2002 · Journal of Immunological Methods
  70. Optimizing Therapeutic Antibody Function
    Etsuji Kaneko, Rinpei Niwa · 2010 · BioDrugs
  71. Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
    Anna Birukov, Branimir Plavša, Fabian Eichelmann, Olga Kuxhaus, Rosângela Akemi Hoshi, Najda Rudman, Tamara Štambuk, Irena Trbojević‐Akmačić, Catarina Schiborn, Jakub Morze et al. · 2022 · Diabetes Care
  72. Production of monoclonal antibodies with a controlledN‐glycosylation pattern in seeds ofArabidopsis thaliana
    Andreas Loos, Bart Van Droogenbroeck, Stefan Hillmer, Josephine Grass, Renate Kunert, Jingyuan Cao, David G. Robinson, Ann Depicker, Herta Steinkellner · 2010 · Plant Biotechnology Journal
  73. LC-MS/MS Peptide Mapping with Automated Data Processing for Routine Profiling of N-Glycans in Immunoglobulins
    Bhavana Shah, Xinzhao Grace Jiang, Louise Chen, Zhongqi Zhang · 2014 · Journal of the American Society for Mass Spectrometry
  74. IgG-Fc glycoengineering in non-mammalian expression hosts
    Andreas Loos, Herta Steinkellner · 2012 · Archives of Biochemistry and Biophysics
  75. A Novel Glycoengineered Bispecific Antibody Format for Targeted Inhibition of Epidermal Growth Factor Receptor (EGFR) and Insulin-like Growth Factor Receptor Type I (IGF-1R) Demonstrating Unique Molecular Properties
    Juergen M. Schanzer, Katharina Wartha, Rebecca Croasdale, Samuel Moser, Klaus‐Peter Künkele, Carola Hermine Ries, Werner Scheuer, Harald Dürr, Sandra Pompiati, Jan Pollman et al. · 2014 · Journal of Biological Chemistry
  76. Protective mechanisms of IVIG
    Raphael Clynes · 2007 · Current Opinion in Immunology
  77. Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies — Impact of effector cells
    Shan Chung, Yuwen Linda Lin, Chae Reed, Carl Ng, Zhi-jie Jey Cheng, Fabio Malavasi, Jihong Yang, Valerie E. Quarmby, An Song · 2014 · Journal of Immunological Methods
  78. Plant glyco-biotechnology on the way to synthetic biology
    Andreas Loos, Herta Steinkellner · 2014 · Frontiers in Plant Science
  79. Ligand‐Based Vascular Targeting of Disease
    Jascha‐N. Rybak, Eveline Trachsel, Jörg Scheuermann, Dario Neri · 2006 · ChemMedChem
  80. Skewed Fc Glycosylation Profiles of Anti-proteinase 3 Immunoglobulin G1 Autoantibodies from Granulomatosis with Polyangiitis Patients Show Low Levels of Bisection, Galactosylation, and Sialylation
    Manfred Wuhrer, Kathrin Stavenhagen, Carolien A. M. Koeleman, Maurice H. J. Selman, Lorraine Harper, Bart C. Jacobs, Caroline O. S. Savage, Roy Jefferis, André M. Deelder, Matthew David Morgan · 2015 · Journal of Proteome Research
  81. Using cell engineering and omic tools for the improvement of cell culture processes
    Darrin Kuystermans, Britta Krampe, Halina Swiderek, Mohamed Al‐Rubeai · 2007 · Cytotechnology
  82. The Current Status and Prospects of Antibody Engineering for Therapeutic Use: Focus on Glycoengineering Technology
    Rinpei Niwa, Mitsuo Satoh · 2015 · Journal of Pharmaceutical Sciences
  83. Glycoprofiling effects of media additives on IgG produced by CHO cells in fed‐batch bioreactors
    Helene Faustrup Kildegaard, Yuzhou Fan, Jette Wagtberg Sen, B. S. Larsen, Mikael Rørdam Andersen · 2015 · Biotechnology and Bioengineering
  84. The present and future of immunocytokines for cancer treatment
    Dennis Y. Gout, Lotte S. Groen, Marjolein van Egmond · 2022 · Cellular and Molecular Life Sciences
  85. Expression of rat β(1,4)‐N‐acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant‐specific N‐glycosylation
    Alexander D. Frey, Saskia R. Karg, Pauli T. Kallio · 2008 · Plant Biotechnology Journal
  86. NK Cells in the Treatment of Hematological Malignancies
    Ana Pilar González, Mónica Villa-Álvarez, Christian Sordo‐Bahamonde, Seila Lorenzo‐Herrero, Segundo R. Gonzalez · 2019 · Journal of Clinical Medicine
  87. Novel promoter/transactivator configurations for macrolide‐ and streptogramin‐responsive transgene expression in mammalian cells
    Wilfried Weber, Beat P. Kramer, Cornelia Fux, Bettina Keller, Martin Fussenegger · 2002 · The Journal of Gene Medicine
  88. Glycosylation flux analysis reveals dynamic changes of intracellular glycosylation flux distribution in Chinese hamster ovary fed-batch cultures
    Sandro Hutter, Thomas K. Villiger, David Brühlmann, Matthieu Stettler, Hervé Broly, Miroslav Šoóš, Rudiyanto Gunawan · 2017 · Metabolic Engineering
  89. Engineering orthogonal human O-linked glycoprotein biosynthesis in bacteria
    Aravind Natarajan, Thapakorn Jaroentomeechai, Marielisa Cabrera-Sánchez, Jody C. Mohammed, Emily C. Cox, Olivia Young, Asif Shajahan, Michael Vilkhovoy, Sandra Vadhin, Jeffrey D. Varner et al. · 2020 · Nature Chemical Biology
  90. Antitumor Antibodies in the Treatment of Cancer: Fc Receptors Link Opsonic Antibody with Cellular Immunity
    Raphael Clynes · 2006 · Hematology/Oncology Clinics of North America
  91. The Absence of Core Fucose Up-regulates GnT-III and Wnt Target Genes
    Ayako Kurimoto, Shinobu Kitazume, Yasuhiko Kizuka, Kazuki Nakajima, Ritsuko Oka, Reiko Fujinawa, Hiroaki Korekane, Yoshiki Yamaguchi, Yoshinao Wada, Naoyuki Taniguchi · 2014 · Journal of Biological Chemistry
  92. Molecular aspects of human FcγR interactions with IgG: Functional and therapeutic consequences
    Sophie Sibéril, Charles‐Antoine Dutertre, Charlotte Boix, Emmanuelle Bonnin, Renée Ménez, Enrico Adriano Stura, Sylvie Jorieux, Wolf H. Fridman, Jean‐Luc Teillaud · 2006 · Immunology Letters
  93. Capillary electrophoresis for the analysis of glycoprotein pharmaceuticals
    Satoru Kamoda, Kazuaki Kakehi · 2006 · Electrophoresis
  94. In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase
    Dale E. Warnock, Xiaomei Bai, Katie Autote, Johnny Gonzales, Kyle Kinealy, Boxu Yan, Jun Qian, Tom Stevenson, David A. Zopf, Robert J. Bayer · 2005 · Biotechnology and Bioengineering
  95. Antibody-Based Vascular Tumor Targeting
    Christoph Schliemann, Dario Neri · 2009 · Recent results in cancer research/Recent Results in Cancer Research
  96. Prediction of Collision-Induced Dissociation Spectra of Common N -Glycopeptides for Glycoform Identification
    Zhongqi Zhang, Bhavana Shah · 2010 · Analytical Chemistry
  97. Glycosylation of Antibody Therapeutics: Optimisation for Purpose
    Jefferis Roy · 2009 · Methods in molecular biology
  98. On enzymatic remodeling of IgG glycosylation; unique tools with broad applications
    Jonathan Sjögren, Rolf Lood, Andreas Naegeli · 2019 · Glycobiology
  99. Site-Specific Glycosylation of an Aglycosylated Human IgG1-Fc Antibody Protein Generates Neoglycoproteins with Enhanced Function
    Gregory M. Watt, John Lund, Michaela Levens, V. S. Kumar Kolli, Royston Jefferis, Geert‐Jan Boons · 2003 · Chemistry & Biology
  100. Streptogramin- and tetracycline-responsive dual regulated expression of p27Kip1 sense and antisense enables positive and negative growth control of Chinese hamster ovary cells
    Cornelia Fux · 2001 · Nucleic Acids Research